Talphera (TLPH) Long-Term Debt Repayments (2010 - 2023)
Talphera (TLPH) recorded quarterly Long-Term Debt Repayments of $3.3 million in Q2 2023, up 60.01% quarter-over-quarter from $2.1 million in Q1 2023, and up 60.01% on a YoY basis from $2.1 million in Q2 2022.
Talphera (TLPH) Long-Term Debt Repayments (2010 - 2023) Analysis & Trends
Talphera's Long-Term Debt Repayments history runs 10 years deep, the most recent figure standing at $3.3 million for Q2 2023.
- In Q2 2023, Long-Term Debt Repayments rose 60.01% year-over-year to $3.3 million; the TTM figure through Mar 2024 stood at $3.3 million (down 60.48% YoY), while the FY2023 annual figure was $5.4 million, down 35.78% from the prior year.
- Long-Term Debt Repayments was $3.3 million for Q2 2023 at Talphera, up from $2.1 million in the prior quarter.
- In the past five years, Long-Term Debt Repayments ranged from a high of $3.3 million in Q2 2023 to a low of $1.4 million in Q2 2019.
- Historically, Long-Term Debt Repayments has averaged $2.2 million across 5 years, with a median of $2.1 million in 2020.
- The sharpest annual moves came in 2019 and 2023: Long-Term Debt Repayments declined 25.96% in 2019, then surged 60.01% in 2023.
- A 5-year view of Long-Term Debt Repayments shows it stood at $1.4 million in 2019, then jumped by 48.22% to $2.1 million in 2020, then fell by 0.05% to $2.1 million in 2021, then gained by 4.8% to $2.2 million in 2022, then soared by 52.68% to $3.3 million in 2023.
- The last three Long-Term Debt Repayments figures came in at $3.3 million (Q2 2023), $2.1 million (Q1 2023), and $2.2 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 23.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 216,000.00 |
| 10 | Talphera | 56.42 Mn | 56.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 3.33 Mn |
| Jun 30, 2023 | 3.33 Mn |
| Mar 31, 2023 | 2.08 Mn |
| Mar 31, 2023 | 2.08 Mn |
| Dec 31, 2022 | 2.18 Mn |
| Dec 31, 2022 | 2.18 Mn |
| Sep 30, 2022 | 2.08 Mn |
| Sep 30, 2022 | 2.08 Mn |
| Jun 30, 2022 | 2.08 Mn |
| Jun 30, 2022 | 2.08 Mn |
| Mar 31, 2022 | 2.08 Mn |
| Mar 31, 2022 | 2.08 Mn |
| Dec 31, 2021 | 2.08 Mn |
| Dec 31, 2021 | 2.08 Mn |
| Sep 30, 2021 | 2.58 Mn |
| Sep 30, 2021 | 2.58 Mn |
| Jun 30, 2021 | 2.08 Mn |
| Jun 30, 2021 | 2.08 Mn |
| Mar 31, 2021 | 2.08 Mn |
| Mar 31, 2021 | 2.08 Mn |